New Formulations of Stimulants for Attention-Deficit Hyperactivity Disorder: Therapeutic Potential

Author： Daniel F. Connor   Ronald J. Steingard  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.18, Iss.14, 2004-01, pp. : 1011-1030

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lisdexamfetamine Dimesylate: A New Therapeutic Option for Attention-Deficit Hyperactivity Disorder

By Steer Christopher  

CNS Drugs, Vol. 26, Iss. 8, 2012-08 ,pp. : 691-705

Adis International

Access to resources Recommend Favorite

Compliance with Stimulants for Attention-Deficit/ Hyperactivity Disorder: Issues and Approaches for Improvement

By Swanson J.  

CNS Drugs, Vol. 17, Iss. 2, 2003-01 ,pp. : 117-131

Adis International

Access to resources Recommend Favorite

The Role of Stimulants in the Treatment of Preschool Children with Attention-Deficit Hyperactivity Disorder

By Christopher J. Kratochvil  

CNS Drugs, Vol. 18, Iss. 14, 2004-01 ,pp. : 957-966

Adis International

Access to resources Recommend Favorite

Substance Abuse in Patients with Attention-Deficit Hyperactivity Disorder: Therapeutic Implications

By Schubiner Howard  

CNS Drugs, Vol. 19, Iss. 8, 2005-01 ,pp. : 643-655

Adis International

Access to resources Recommend Favorite

‘Pay attention’ to stimulants in attention-deficit hyperactivity disorder when other psychiatric disorders exist

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 8, 2004-08 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite